Incretin-based therapies in 2021 – Current status and perspectives for the future
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incretin-based therapies in 2021 – Current status and perspectives for the future
Authors
Keywords
-
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 122, Issue -, Pages 154843
Publisher
Elsevier BV
Online
2021-07-30
DOI
10.1016/j.metabol.2021.154843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action
- (2021) Francesco Maranta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6
- (2021) Michael A. Nauck et al. Frontiers in Endocrinology
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 and diabetes management: What should be considered?
- (2020) Antonio Ceriello et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
- (2020) Anca Pantea Stoian et al. Metabolic Syndrome and Related Disorders
- COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next
- (2020) Angeliki M. Angelidi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Issues for the management of people with diabetes and COVID-19 in ICU
- (2020) Antonio Ceriello et al. Cardiovascular Diabetology
- Diabetes and COVID-19: IDF perspective in the Western Pacific region
- (2020) Yerin Hwang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights
- (2020) Anca Pantea Stoian et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes
- (2020) Anca Pantea Stoian et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?
- (2020) Melanie J. Davies et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Commentary: COVID-19 in patients with diabetes
- (2020) Michael A. Hill et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
- (2020) Guntram Schernthaner et al. Cardiovascular Diabetology
- COVID-19 in people living with diabetes: An international consensus
- (2020) A.E. Caballero et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
- (2020) Alexandros Sachinidis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
- (2020) Dragana Nikolic et al. Diabetes Therapy
- Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa
- (2020) Francesco Giorgino et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel
- (2020) Maciej Banach et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The incretin system in healthy humans: The role of GIP and GLP-1
- (2019) Jens Juul Holst METABOLISM-CLINICAL AND EXPERIMENTAL
- Of mice and men: incretin actions in the central nervous system
- (2019) Olivia M. Farr et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin
- (2019) Anastasia-Stefania Alexopoulos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
- (2019) Johan Farngren et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
- (2019) Alexander Kokkinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
- (2019) Michael A. Nauck METABOLISM-CLINICAL AND EXPERIMENTAL
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure
- (2019) Francesco Giorgino et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Incretin-based therapies: where will we be 50 years from now?
- (2015) Juris J. Meier et al. DIABETOLOGIA
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now